{
    "nctId": "NCT05622227",
    "briefTitle": "68Ga PET/CT Imaging in Breast Cancer Patients",
    "officialTitle": "68Ga-P16-093 PET/CT Imaging in Primary and Recurrent Breast Cancer Patients",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Diagnostic performance",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* breast cancer patients highly suggested by ultrasound or histologically confirmed;\n* 68Ga-P16-093 PET/CT and 18F-FDG within two weeks;\n* signed written consent.\n\nExclusion Criteria:\n\n* known allergy against PSMA;\n* any medical condition that in the opinion of the investigator may significantly interfere with study compliance.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}